宫颈癌辐射抵抗机制的相关研究进展

Abstract
Figure/Table
References (35)
Related Citation (15)

Download: PDF (504 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Cervical cancer is the most common malignant tumor of female reproductive system, middle and advanced stage and postoperative high-risk factors of early cervical cancer need supplementary treatment, mainly radiotherapy. Improving the sensitivity of cervical cancer to radiation has always been an urgent problem for gynecological oncologists. Recent studies have found that radioresistance of cervical cancer is closely related to cancer stem cell, DNA damage repair, and tumor microenvironment. The mechanisms of radioresistance induced by cancer stem cell include epithelial-mesenchymal transformation, hypoxia, oxidative regulation, intracellular phagocytosis, and inflammatory reaction, etc. Factors related to DNA damage repair pathway, such as ataxic telangiectasia-mutant gene, ATM-Rad3-related protein kinase, and genes interacting with the pathway, may be targets for improving radiotherapy sensitivity. Some factors in tumor microenvironment play a role in radioresistance of cervical cancer. The above factors are interrelated and interact with each other, and their specific mechanism of action affects the sensitivity and efficacy of radiotherapy for cervical cancer. This paper reviews the research progress on the mechanism of radioresistance of cervical cancer.

Key words： Cervical cancer Radioresistance Cancer stem cell DNA damage repair Tumor microenvironment

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JI Chen WU Yumei

Cite this article:

JI Chen WU Yumei. Research progress on radioresistance mechanism of cervical cancer#br#[J]. 中国医药导报, 2021, 18(35): 46-49.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I35/46

[1] Legge F，Chiantera V，Macchia G，et al. Clinical outcome of recurrent locally advanced cervical cancer（LACC）submitted to primary multimodality therapies [J]. Gynecol Oncol，2015，138（1）：83-88.
[2] Sia J，Szmyd R，Hau E，et al. Molecular Mechanisms of Radiation-Induced Cancer Cell Death：A Primer [J]. Front Cell Dev Biol，2020，8：41.
[3] Vitti ET，Parsons JL. The Radiobiological Effects of Proton Beam Therapy：Impact on DNA Damage and Repair [J]. Cancers（Basel），2019，11（7）：946.
[4] Rajaraman P，Hauptmann M，Bouffler S，et al. Human individual radiation sensitivity and prospects for prediction [J]. Ann ICRP，2018，47（3/4）：126-141.
[5] Hur W，Yoon SK. Molecular Pathogenesis of Radiation-Induced Cell Toxicity in Stem Cells [J]. Int J Mol Sci，2017， 18（12）：2749.
[6] Arnold CR，Mangesius J，Skvortsova I，et al. The Role of Cancer Stem Cells in Radiation Resistance [J]. Front Oncol，2020，10：164.
[7] Atashzar MR，Baharlou R，Karami J，et al. Cancer stem cells：a review from origin to therapeutic implications [J]. J Cell Physiol，2020，235（2）：790-803.
[8] Bjerkvig R，Tysnes BB，Aboody KS，et al. Opinion：the origin of the cancer stem cell：current controversies and new insights [J]. Nat Rev Cancer，2005，5（11）：899-904.
[9] Lau EY，Ho NP，Lee TK. Cancer stem cells and their microenvironment：biology and therapeutic implications [J]. Stem Cells Int，2017，2017：3714190.
[10] Wu MJ，Chen YS，Kim MR，et al. Epithelial-mesenchymal transition directs stem cell polarity via regulation of mitofusin [J]. Cell Metab，2019，29（4）：993-1002.
[11] Lytle NK，Ferguson LP，Rajbhandari N，et al. A multiscale map of the stem cell state in pancreatic adenocarcinoma [J]. Cell，2019，177（3）：572-586.
[12] Filipponi D，Emelyanov A，Muller J，et al. DNA damage signaling-induced cancer cell reprogramming as a driver of tumor relapse [J]. Mol Cell，2019，74（4）：651-663.
[13] Lee IC，Wu YC，Hung WS. Hyaluronic acid-based multilayer films regulate hypoxic multicellular aggregation of pancreatic cancer cells with distinct cancer stem-cell-like properties [J]. ACS Appl Mater Interfaces，2018，10（45）：38769-38779.
[14] Dauer P，Sharma NS，Gupta VK，et al. ER stress sensor，glucose regulatory protein78（GRP78）regulates redox status in pancreatic cancer thereby maintaining “stemness” [J]. Cell Death Dis，2019，10（2）：132.
[15] Eckert F，Zwirner K，Boeke S，et al. Rationale for combining radio therapy and immune check point inhibition for patients with hypoxic tumors [J]. Front Immunol，2019， 10：407.
[16] Anuja K，Chowdhury AR，Saha A，et al. Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells [J]. Int J Radiat Biol，2019，95（6）：667-679.
[17] You Y，Bi FF，Jiang Y，et al. BRCA1 affects the resistance and stemness of SKOV3-derived ovarian cancer stem cells by regulating autophagy [J]. Cancer Med，2019， 8（2）：656-668.
[18] Ubil E，Caskey L，Holtzhausen A，et al. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response [J]. J Clin Invest，2018，128（6）：2356-2369.
[19] Zhao PF，Wang YH，Kang XJ，et al. Dual-targeting bio-mimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy [J]. Chem Sci，2018，9（10）：2674-2689.
[20] Chhabra R. Cervical cancer stem cells：opportunities and challenges [J]. J Cancer Res Clin Oncol，2015，141（11）：1889-1897.
[21] Cai JH，He BX，Li XM，et al. Regulation of tumorigenesis in oral epithelial cells by defined reprogramming factors Oct4 and SOX2 [J]. Oncol Rep，2016，36（2）：651-658.
[22] Rachmadi L，Siregar NC，Kanoko M，et al. Role of Cancer Stem Cell，Apoptotic Factor，DNA Repair，and Telomerase Toward Radiation Therapy Response in Stage ⅢB Cervical Cancer [J]. Oman Med J，2019，34（3）：224-230.
[23] Liu XF，Yang WT，Xu R，et al. Cervical cancer cells with positive SOX2 expression exhibit the properties of cancer stem cells [J]. PLoS One，2014，9（1）：e87092.
[24] Roossink F，Wieringa HW，Noordhuis MG，et al. The role of ATM and 53BP1 as predictive markers in cervical cancer [J]． Int J Cancer，2012，131（9）：2056-2066．
[25] Agnihotri S，Burrell K，Buczkowicz P，et al. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents [J]. Cancer Discov，2014，4（10）：1198-1213.
[26] Stagni V，Santini S，Barila D. ITCH E3 ligase in ATM network [J]. Oncoscience，2014，1（6）：394-395.
[27] Fokas E，Prevo R，Pollard JR，et al. Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation [J]. Cell Death Dis，2012，3（12）：e441.
[28] Werner LR，Huang S，Francis DM，et al. Small molecule inhibition of MDM2-p53 interaction augments radiation response in human tumors [J]. Mol Cancer Ther，2015，14（9）：1994-2003．
[29] 刘洋，吴玉梅，周平坤，等.早期快速反应基因5和Ku70与宫颈癌放疗敏感性及临床意义的相关性研究[J].中国综合临床，2016，32（12）：1057-1061.
[30] Yu XP，Wu YM，Zhou PK，et al. IER5 is involved in DNA Double-Strand Breaks Repair in Association with PAPR1 in Hela Cells [J]. Int J Mol Sci，2017，14（12）：1292-1300.
[31] Sample KM. DNA repair gene expression is associated with differential prognosis between HPV16 and HPV18 positive cervical cancer patients following radiation therapy [J]. Sci Rep，2020，10（1）：2774.
[32] Nola RD，Menga A，Castegna A，et al. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies：Biological Pathways and Therapeutic Implication [J]. Int J Mol Sci，2019， 20（10）：2401.
[33] Ren C，Cheng X，Lu B，et al. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papilloma virus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through auto crine and paracrine pathways in tumour microenvironment [J]. Eur J Cancer，2013，49（18）：3889-3899.
[34] Wang YB，Gan GF，Wang BC，et al. Cancer-associated fibroblasts promote irradiated cancer cell recovery through autophagy [J]. EBioMedicine，2017，17：45-56.
[35] Matsui WH. Cancer stem cell signaling pathways [J]. Medicine（Baltimore），2016，95（1 Suppl 1）：S8-S19.